Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02508428 · ClinicalTrials.gov registry record · NA
Marathon and Enduron Polyethylene at Long-Term Follow-up
A NA study of Osteoarthritis and Arthritis, sponsored by Anderson Orthopaedic Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 1
- Study location
NCT02508428: Completed NA study of Osteoarthritis and Arthritis, sponsored by Anderson Orthopaedic Research Institute.
NCT02508428 is a NA study of Osteoarthritis and Arthritis that has completed, run by Anderson Orthopaedic Research Institute. The registered enrollment target is 230 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02508428, a NA study of Osteoarthritis and Arthritis, has completed, sponsored by Anderson Orthopaedic Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether crosslinked Marathon and standard Enduron polyethylene liners show differences in survivorship due to wear-related revisions at minimum 14-year follow-up and every 5 years after.
Primary Outcome
Kaplan-Meier survivorship was calculated using revision for wear/osteolysis as an endpoint.
Conditions Studied
Interventions
- DEVICE Hip Replacement with crosslinked Marathon polyethylene
- DEVICE Hip Replacement with noncrosslinked Enduron polyethylene
Study Locations (1)
Virginia
- Anderson Orthopaedic Research Institute - Alexandria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 1999-01-06 |
| Est. Completion | 2017-06-22 |
| Phase | NA |
What the finished NCT02508428 record still lists
NCT02508428 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (72% lower).
The record links to 5 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Hip Replacement with crosslinked Marathon polyethylene is the first listed.
NCT02508428 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT02508428 about?
NCT02508428 is a clinical study titled "Marathon and Enduron Polyethylene at Long-Term Follow-up". The purpose of the study is to determine whether crosslinked Marathon and standard Enduron polyethylene liners show differences in survivorship due to wear-related revisions at minimum 14-year follow-up and every 5 years after.
What is the current status of trial NCT02508428?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 1999-01-06. Estimated completion is 2017-06-22.
What conditions does trial NCT02508428 study?
This clinical trial studies the following conditions: Osteoarthritis, Arthritis, Musculoskeletal Diseases, Rheumatic Diseases, Joint Diseases.
What interventions are being tested in trial NCT02508428?
The interventions under investigation include: Hip Replacement with crosslinked Marathon polyethylene (DEVICE), Hip Replacement with noncrosslinked Enduron polyethylene (DEVICE).
Who is sponsoring clinical trial NCT02508428?
This trial is sponsored by Anderson Orthopaedic Research Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02508428 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02508428's enrollment target sits among peer trials
230 51st of 135 higher than 85 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI